Intracranial delivery of antisense locked nucleic acids for silencing microRNAs in the mouse brain

被引:0
|
作者
Sharma, Nikhil [1 ]
Sen, Ganes C. [1 ]
机构
[1] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, 9500 Euclid Ave, Cleveland, OH 44195 USA
来源
STAR PROTOCOLS | 2022年 / 3卷 / 04期
基金
美国国家卫生研究院;
关键词
Gene expression; Model organisms; Molecular biology; Neuroscience;
D O I
10.1016/j.xpro.2022.101836
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Antisense locked nucleic acid (LNA) technology has been widely used for silencing microRNAs with enhanced specificity and efficiency. In this protocol, we first describe the procedure for targeted intracranial delivery of LNAs to silence microRNAs specifically in the mouse brain. We then detail the steps to isolate RNA and protein from mouse brain, followed by using RT-PCR and West-ern blotting to confirm microRNA silencing. This noninvasive approach can only be applied to mouse brain to specifically target silencing of microRNAs. For complete details on the use and execution of this protocol, please refer to Sharma et al. (2021).1
引用
收藏
页数:10
相关论文
共 50 条
  • [21] A STUDY OF BRAIN LIPIDS NUCLEIC ACIDS AND PROTEINS IN ATAXIC (AXJ) MOUSE
    WEBER, MB
    NEUROLOGY, 1968, 18 (03) : 243 - +
  • [22] The intratracheal administration of locked nucleic acid containing antisense oligonucleotides induced gene silencing and an immune-stimulatory effect in the murine lung
    Uemura, Yasunori
    Hagiwara, Kenji
    Kobayashi, Katsuya
    PLOS ONE, 2017, 12 (11):
  • [23] Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy
    Wojtkowiak-Szlachcic, Agnieszka
    Taylor, Katarzyna
    Stepniak-Konieczna, Ewa
    Sznajder, Lukasz J.
    Mykowska, Agnieszka
    Sroka, Joanna
    Thornton, Charles A.
    Sobczak, Krzysztof
    NUCLEIC ACIDS RESEARCH, 2015, 43 (06) : 3318 - 3331
  • [24] Antisense locked nucleic acids efficiently suppress BCR/ABL and induce cell growth decline and apoptosis in leukemic cells
    Rapozzi, Valentina
    Cogoi, Susanna
    Xodo, Luigi E.
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (07) : 1683 - 1692
  • [25] Multifunctional receptor-targeted nanocomplexes for the delivery of therapeutic nucleic acids to the Brain
    Kenny, Gavin D.
    Bienemann, Alison S.
    Tagalakis, Aristides D.
    Pugh, John A.
    Welser, Katharina
    Campbell, Frederick
    Tabor, Alethea B.
    Hailes, Helen C.
    Gill, Steven S.
    Lythgoe, Mark F.
    McLeod, Cameron W.
    White, Edward A.
    Hart, Stephen L.
    BIOMATERIALS, 2013, 34 (36) : 9190 - 9200
  • [26] Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design
    Braasch, DA
    Liu, YH
    Corey, DR
    NUCLEIC ACIDS RESEARCH, 2002, 30 (23) : 5160 - 5167
  • [27] Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model
    Delgado, Evan
    Okabe, Hirohisa
    Preziosi, Morgan
    Russell, Jacquelyn Olivia
    Alvarado, Tamara Feliciano
    Oertel, Michael
    Nejak-Bowen, Kari Nichole
    Zhang, Yixian
    Monga, Satdarshan P. S.
    JOURNAL OF HEPATOLOGY, 2015, 62 (02) : 380 - 387
  • [28] In vitro selection and delivery of specifically hybridizing bcr-abl-directed antisense nucleic acids and ribozymes.
    Kronenwett, R
    Haas, R
    Sczakiel, G
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 166 - 166
  • [29] Tetrahedral Framework Nucleic Acids Loaded with Aptamer AS1411 for siRNA Delivery and Gene Silencing in Malignant Melanoma
    Xiao, Dexuan
    Li, Yanjing
    Tian, Taoran
    Zhang, Tianxu
    Shi, Sirong
    Lu, Boyao
    Gao, Yang
    Qin, Xin
    Zhang, Mei
    Wei, Wei
    Lin, Yunfeng
    ACS APPLIED MATERIALS & INTERFACES, 2021, 13 (05) : 6109 - 6118
  • [30] Novel customized releasable polyethylene glycol (PEG) linkers improve tumor delivery and efficacy of locked nucleic acids oligonucleotides
    Sapra, P.
    Zhao, H.
    Reddy, P.
    Wang, M.
    Bhandaru, R.
    Malaby, J.
    Kraft, P.
    Mehlig, M.
    Greenberger, L. M.
    Horak, I. D.
    EJC SUPPLEMENTS, 2008, 6 (12): : 40 - 40